本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Benitec Biopharma Limited

11.08
+0.02500.23%
成交量:9,030
成交額:10.08萬
市值:3.86億
市盈率:-10.00
高:11.35
開:11.09
低:11.01
收:11.05
52周最高:16.76
52周最低:9.85
股本:3,488.27萬
流通股本:1,845.34萬
量比:0.48
換手率:0.05%
股息:- -
股息率:- -
每股收益(TTM):-1.1074
每股收益(LYR):-0.9800
淨資產收益率:-33.21%
總資產收益率:-22.67%
市淨率:2.18
市盈率(LYR):-11.30

資料載入中...

2020/02/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/12

SEC問詢函

[Cover]Correspondence
2019/12/09

招股説明書

Registration statement for certain foreign private issuers
2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/30

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/10/08

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/07

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]